VISCOAT(TM)/DVOVISC/DISCOVISC OPHTHALMIC VISCOSURGICAL DEVICES
Alcon Laboratories · Decision date Apr 30, 1986
What did the FDA approve?
FDA records P840064 as an original PMA application. The recorded decision is approval, dated Apr 30, 1986.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ophthalmic
- Decision date
- Apr 30, 1986
Regulatory record facts
- Identifier
- P840064
- Regulatory pathway
- Premarket approval application
- Applicant
- Alcon Laboratories
- Product code
- LZP
- Decision code
- APPR
- Decision date
- Apr 30, 1986
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: AID, SURGICAL, VISCOELASTIC.
- Applicant
- Alcon Laboratories
- Product code
- LZP
- FDA device class
- 3
FDA decision timeline
P840064 received
Application receipt date recorded by FDA.
P840064 · FDA decision
APPR
P840064/S094 · Related supplement
VISCOAT Ophthalmic Viscosurgical Device; DUOVISC Ophthalmic Viscosurgical System; DISCOVISC Ophthalmic Viscosurgical
Timeline entries are records held by MedtechLedger for P840064. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P840064
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Alcon Laboratories | PMA supplement | Oct 1, 2026 | FDA |
Explore the linked device profile
Other records with product code LZP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
PROVISC Ophthalmic Viscosurgical DeviceP890047/S072 | Alcon Research, Ltd. | PMA supplement | Oct 1, 2026 | FDA |
| Alcon Research, Ltd. | PMA approval | Sep 26, 1991 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Jan 14, 1983 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Alcon Laboratories
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6201 S. Fwy., Fort Worth, TX, 76134
Sources and methodology
- Original FDA record: P840064
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



